Cargando…
S100A8/A9 and S100A9 reduce acute lung injury
S100A8 and S100A9 are myeloid cell-derived proteins that are elevated in several types of inflammatory lung disorders. Pro- and anti-inflammatory properties are reported and these proteins are proposed to activate TLR4. S100A8 and S100A9 can function separately, likely through distinct receptors but...
Autores principales: | Hiroshima, Yuka, Hsu, Kenneth, Tedla, Nicodemus, Wong, Sze Wing, Chow, Sharron, Kawaguchi, Naomi, Geczy, Carolyn L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454315/ https://www.ncbi.nlm.nih.gov/pubmed/28074060 http://dx.doi.org/10.1038/icb.2017.2 |
Ejemplares similares
-
Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment
por: Wong, Sze Wing, et al.
Publicado: (2022) -
S100A12 Suppresses Pro-inflammatory, but Not Pro-Thrombotic Functions of Serum Amyloid A
por: Chung, Yuen Ming, et al.
Publicado: (2013) -
TLR9 Ligands Induce S100A8 in Macrophages via a STAT3-Dependent Pathway which Requires IL-10 and PGE(2)
por: Hsu, Kenneth, et al.
Publicado: (2014) -
S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia
por: Liao, Wei-Chih, et al.
Publicado: (2023) -
S100A8 and S100A9 in experimental osteoarthritis
por: Zreiqat, Hala, et al.
Publicado: (2010)